We examined the role of increased expression of HGFR kinase in in vivo growth of renal carcinoma. Human renal carcinoma cell line, ACHN cells, was transfected with plasmid encoding wild-type HGFR gene to generate cell lines with increased HGFR protein. ACHN cells with elevated HGFR expression, denoted clones 8 and 10, respectively, showed higher basal kinase activities of HGFR and PI3-kinase than those of empty-vector (mock)-transfected cells. Clone 8 and 10 cells grew similar to mock cells in culture. In mice, tumors of these clones grew more rapidly than those of mock cells. Microvessel density of clone 8 or 10 tumors was higher than that of mock tumors. Clone 8 and 10 cells secreted vascular endothelial growth factor-A (VEGF-A) more than mock cells and the secretion was PI3-kinase inhibitor, LY294002-sensitive. Anti-VEGF-A neutralizing antibody significantly inhibited tumor growth of clones 8 and 10 in mice. These results indicate for the first time that overexpression of HGFR tyrosine kinase in renal carcinoma cells participates in rapid tumor growth in vivo. (C) 2003 Elsevier Science (USA). All rights reserved.
JIA XiaoqinCHENG HaiqingLI HongZHU YanLI YuhuaFENG Zhenqing and ZHANG Jianping Department of PathologySchool of MedicineYangzhou UniversityYangzhouJiangsu China Department of PathologyNanjing Medical UniversityNanjing Jiangsu China Key Laboratory of Antibody TechniqueMinistry of Health Nanjing Medical UniversityNanjingJiangsu China Department of General Surgerythe Second Affiliated Hospital of Nanjing Medical UniversityNanjingJiangsu China
论文数: 0引用数: 0
h-index: 0
JIA XiaoqinCHENG HaiqingLI HongZHU YanLI YuhuaFENG Zhenqing and ZHANG Jianping Department of PathologySchool of MedicineYangzhou UniversityYangzhouJiangsu China Department of PathologyNanjing Medical UniversityNanjing Jiangsu China Key Laboratory of Antibody TechniqueMinistry of Health Nanjing Medical UniversityNanjingJiangsu China Department of General Surgerythe Second Affiliated Hospital of Nanjing Medical UniversityNanjingJiangsu China
机构:
Yangzhou Univ, Dept Pathol, Sch Med, Yangzhou 225500, Jiangsu, Peoples R China
Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China
Jia Xiao-qin
Cheng Hai-qing
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China
Cheng Hai-qing
Li Hong
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China
Li Hong
Zhu Yan
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China
Zhu Yan
Li Yu-hua
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China
Li Yu-hua
Feng Zhen-qing
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Dept Pathol, Nanjing 210029, Jiangsu, Peoples R China
Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing 210029, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China
Feng Zhen-qing
Zhang Jian-ping
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing 210011, Jiangsu, Peoples R China